The procedures were performed in Italy and Sweden. The system was designed for less wear than a metal resurfacing implant. It is intended for use in patients who have glenohumeral joint disease due to non-inflammatory, inflammatory and post-traumatic arthritis.
More Articles on Orthopedic Devices:
15 of the Most Profitable Orthopedic & Spine Device Companies in 2011
U.S. Orthopedic & Spine Bracing Market to Reach $2B in 2012
Generic Orthopedic Implant Company Signs Agreement With Premier
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
